Bivalirudin cardiopulmonary bypass

Author: khwh

August undefined, 2024

WebMar 1, 2024 · The reported doses of bivalirudin in patients undergoing cardiac surgery with cardiopulmonary bypass circulation include bolus of 0.75 to 2.5 mg/kg, followed by a continuous infusion at the titrated rate of 1.75 to 2.5 mg/kg/h [7]. During extracorporeal circulation ACT measurement is used to assess proper bivalirudin dose and the desired … WebApr 29, 2013 · Dyke CM, Smedira NG, Koster A: A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg. 2006, 131: 533-539. 10.1016/j.jtcvs.2005.09.057. Article CAS PubMed Google Scholar

Successful use of bivalirudin for cardiopulmonary bypass in a …

WebBIVALIRUDIN 1. Pre-VAD implantation work-up (<48 hours pre VAD/MCS): • Baseline labs: CBC with diff, aPTT*, PT/INR, fibrinogen, basic metabolic panel (BMP) • Optional labs: TEG with PM, CRP, LDH, cystatin C, HIT screen, ROTEM 2. Intra-op management • Standard heparin anticoagulation for cardiopulmonary bypass with full WebDec 15, 2024 · Bivalirudin reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI). ... During “off-pump” cardiac surgery (i.e., without cardiopulmonary bypass), 0.75 mg/kg by direct IV injection, followed by 1.75 mg/kg per hour by continuous IV infusion to maintain an ACT >300 seconds has been used. try fast

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB …

WebPopulation pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers WebMar 11, 2004 · Drug: Angiomax (bivalirudin) 250 mg vial administered as 1.0 mg/kg intravenous (IV) bolus and 2.5 mg/kg/h IV infusion during the procedure with the option to administer additional 0.1 to 0.5 mg/kg boluses to increase the level of anticoagulation as clinically indicated. A low-dose infusion could have been administered in the preoperative … WebHeparin-induced IgE-mediated hypersensitivity and anaphylactoid reactions, although rare, can pose a serious clinical problem for patients requiring cardiopulmonary bypass … philip waddup activate learning

Reversal of Direct Thrombin Inhibition After Cardiopulmonary ... - LWW

Effect of Combined Anticoagulation Using Heparin and Bivalirudin …

WebAlthough the reported clinical experience with bivalirudin in cardiac surgery is reviewed, operative techniques for the perfusionist/surgeon team are discussed in detail. We recognize that the use of bivalirudin during cardiopulmonary bypass is evolving and modifications of technique will undoubtedly occur as further data and experience accumulate. WebThe literature on bivalirudin use in children is sparse with case reports of its use during cardiopulmonary bypass, 15 in patients with HIT 16 and in a case series of patients who failed ... philip vynckeWebNov 3, 2010 · Antiphospholipid syndrome (APLS) is a rare syndrome mainly characterized by several hyper-coagulable complications and therefore, implicated in the operated cardiac surgery patient. APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus … try feed and grow fish

"WebMar 1, 2024 · After informed consent, 10 sequential patients presenting for elective cardiac surgery requiring cardiopulmonary bypass received bivalirudin anticoagulation in lieu … " - Bivalirudin cardiopulmonary bypass

Bivalirudin cardiopulmonary bypass

Argatroban for Off-Pump Coronary Artery Bypass Surgery : …

WebHIT complicates the management of patients presenting for cardiac surgery, particularly those who need cardiopulmonary bypass (CPB) which requires a large dose of UFH. A portion of these patients will have significant thrombotic complications referred to as HITT (Heparin-induced thrombocytopenia with thrombosis). WebFeb 3, 2024 · A typical adult based bivalirudin regimen during cardiopulmonary bypass uses a loading dose of 1 mg.kg ‐1 and a circuit prime (volume L x 13 mg) with a subsequent intravenous infusion 2.5 mg.h ‐1 .kg ‐1. Dose in children remains unknown. We wished to determine a practical bivalirudin dosing schedule for children undergoing surgery with ...

Did you know?

WebApr 13, 2024 · Use of botulinum toxin A to reduce AF was assessed in the NOVA (NeurOtoxin for the PreVention of Post-Operative Atrial Fibrillation) study which randomised 323 patients undergoing cardiac (bypass and/or valve) surgery to epicardial botulinum toxin A (125 units or 250 units) versus placebo . Overall, botulinum 125 units or 250 units … WebTY - JOUR T1 - Use of bivalirudin as an anticoagulant during cardiopulmonary bypass. AU - Veale,James J, AU - McCarthy,Harry M, AU - Palmer,George, AU - Dyke,Cornelius M, PY - 2005/12/15/pubmed PY - 2006/2/8/medline PY - 2005/12/15/entrez SP - 296 EP - 302 JF - The journal of extra-corporeal technology JO - J Extra Corpor Technol VL - 37 IS - 3 …

WebApr 30, 2011 · Extracorporeal membrane oxygenation (ECMO) after cardiac operations (postcardiotomy) is commonly used for the treatment of acute heart failure refractory to drug treatment. Bleeding and thromboembolic events are the most common complications of postcardiotomy ECMO. The present study is a retrospective comparison of the … WebMay 9, 2012 · Bivalirudin has been proposed as the sole anticoagulant in patients under extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass. Owing to the pharmacodynamic properties of ...

WebThe hypothesis that dabigatran would provide sufficient anticoagulation for cardiopulmonary bypass was tested in a first-use, proof-of-concept study using a rabbit model of cardiopulmonary bypass that included a comparison group receiving heparin. The dabigatran loading dose and maintenance infusions were designed after first … WebOct 1, 2005 · Bivalirudin plasma concentration during cardiopulmonary bypass Weight-based dosing of bivalirudin is possible because of predictable and reliable …

WebThe hypothesis that dabigatran would provide sufficient anticoagulation for cardiopulmonary bypass was tested in a first-use, proof-of-concept study using a rabbit …

WebBivalirudin is metabolized by intracellular proteolysis, with 20% excreted unchanged by the kidneys. Wolstencroft, Arnold and Anderson present a study using allometry to determine appropriate bivalirudin infusion rates for pediatric patients requiring bivalirudin for cardiopulmonary bypass (CPB) anticoagulation 1. try fbaWebBACKGROUND: The coronary artery bypass grafting (CABG) heparin-induced thrombocytopenia thrombosis syndrome (HITTS) on- and off-pump safety and efficacy … tryfender.com tryfemorWebInfants with heparin-induced thrombocytopenia (HIT) represent a challenging and high-risk group of patients when they require cardiopulmonary bypass (CPB). Bivalirudin offers many potential pharmacologic advantages over other nonheparin anticoagulants for such patients. We describe our protocol for … try fba for freeWebA total of 21 adult patients received bivalirudin with infusion rates ranging from 0.028 to 0.2 mg/kg/h with or without initial bolus doses. 10 This wide variability in dosing requirements was also observed in our present analysis with maintenance rates achieving target aPTT ranges of 0.04 to 0.26 mg/kg/h. philip v the tallWebThe various options mentioned in the literature call for changes in the routine practice of open heart surgery on cardiopulmonary bypass. These changes involve mostly the … philip wade mclaughlinWebAnesthesia & Analgesia: June 2004 - Volume 98 - Issue 6 - p 1635-1639. doi: 10.1213/01.ANE.0000114072.71353.D5. Free. We treated persistent hemorrhage after cardiopulmonary bypass in a heart transplant recipient who had received anticoagulation with the direct thrombin inhibitor bivalirudin by a combination therapy aimed at reducing … tryfeet